Universal Biofactor-Releasing Scaffold Enabling in Vivo Reloading.

Area of Science:

• Biomaterials Science
• Tissue Engineering
• Regenerative Medicine

Background:

• Controlled release of growth factors is crucial for engineered tissues.
• Existing systems have limited long-term efficacy due to finite factor supply.
• Need for adaptable systems to meet dynamic physiological requirements.

Purpose of the Study:

• To develop a reloadable scaffold system for sustained and controlled release of proteinaceous growth factors.
• To demonstrate the system's ability to retain and release His-tagged growth factors.
• To evaluate the efficacy of the system in promoting vascularization in vitro and in vivo.

Main Methods:

• Fabrication of 3D fibrous scaffolds conjugated with anti His-tag antibodies.
• Loading and controlled release of His-tagged growth factors (e.g., angiogenic factors, VEGF).
• In vitro studies using static cell culture and microfluidics devices.
• In vivo studies demonstrating sequential reloading and vascularization.

Main Results:

• Scaffolds successfully retained and released His-tagged growth factors.
• Demonstrated controlled release of angiogenic factors affecting endothelial cells in vitro.
• Successful in vivo reloading and significant vascularization of scaffolds with tagged VEGF.

Conclusions:

• The developed reloadable scaffold system offers a promising approach for long-term, on-demand delivery of growth factors in tissue engineering.
• This technology has potential applications in promoting tissue regeneration and vascularization.
• The system's adaptability for in vitro and in vivo use enhances its translational potential.